Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alfa-2b for Diabetic Macular Edema
IRCT20230103057035N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2023
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of interferon alfa-2b in diabetic macular edema (DME), sponsored by Shahid Beheshti University of Medical Sciences. Started Jan 2023; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on IRCT20230103057035N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230103057035N1.